Combining a magnetic nanoparticle, a fluorescent quantum dot, and an anticancer drug within a lipid-based nanoparticle, a multi-institutional research team headed by the National Cancer Institute’s (NCI) Alliance for Nanotechnology in Cancer has created a single agent that can image and treat tumors, while avoiding detection by the immune system, enabling the particle to remain in the body for extended periods of time.